Synthesis and Molecular Pharmacology of the Diazonamides
Burgett, Anthony William George
MetadataShow full item record
Diazonamide A is structurally novel, marine-derived natural product potently capable of inhibiting the growth of the cultured human cancer cell lines in vitro. Following the eassignment of diazonamide structure in 2001, we began a program to understand the compound's cellular mode of action. I determined that the diazonamides are potent antimitotic agents that induce the formation of mono-aster mitotic spindles. The synthesis of numerous analogs established structure activity relationships which guided the preparation of biotinylated, fluorescent, and radiolabeled forms of the natural product. These analogs were used in a variety of experiments to demonstrate diazonamide A effects mitotic spindle assembly in novel manner distinct from conventional tubulin interacting agents. This finding suggests diazonamide A will prove a valuable probe of new cell biology and a unique chemotherapeutic drug lead. The second major focus of my work involved the total synthesis of diazonamide A. The central feature of our approach employed a hypervalent iodine species to oxidatively install the central diazonamide diarylaminal. This net two electron oxidative internal crosslink between tyrosine and tryptophan accesses the diazonamide core from a simple peptide-derived substrate. Building on the discovery, fully synthetic diazonamide A was prepared in a total of 19 operations from 5 segments of comparable complexity. This successful synthesis allows for a truly scalable and practical synthesis of diazonamide structures for further pre-clinical evaluation as new anti-cancer drugs.